Respiratory Unit, Ospedale San Paolo, Department of Health Sciences, Università degli Studi di Milano, Via A. di Rudinì, 8, 20142, Milan, Italy.
Laboratories of Pharmacology, Università degli Studi di Milano, Milan, Italy.
BMC Pulm Med. 2017 Jul 28;17(1):107. doi: 10.1186/s12890-017-0447-x.
Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome, lymphangioleiomyomatosis/tuberous sclerosis complex (LAM-TSC), and sarcoidosis are three rare diseases. Here we present, to the best of our knowledge, the first description of a patient with the coexistence of these three diseases.
A 47-year-old woman affected by LAM-TSC and primary biliary cirrosis/autoimmune hepatitis overlap syndrome. During her follow up a high resolution chest CT scan (HRTC) confirmed the presence of both multiple cysts and micronodular opacities consistent with multifocal micronodular pneumocytes hyperlasia (MMPH), and revealed multiple hilar-mediastinal symmetrical lymphadenopathies suggestive of sarcoidosis. Simultaneously, subcutaneous nodules appeared on her forearm bilaterally. Cutaneous biopsy showed granulomatous dermatitis with sarcoid-like granulomas. A diagnosis of stage I pulmonary sarcoidosis was made. No treatment for sarcoidosis was initiated since the patient had neither systemic involvement, nor respiratory impairment.
The presence of more than one rare disease should challenge the concept of a potential common underlying mechanism, since the a priori probability of the concomitant presence of different conditions with different pathogenic mechanisms - especially if rare diseases - is low. We speculate that the dysregulation of the pathway involving mTOR and MAPK and their interaction might play a role in the pathogenesis of other diseases, including sarcoidosis.
自身免疫性肝炎/原发性胆汁性肝硬化重叠综合征、淋巴管平滑肌瘤病/结节性硬化症复合征(LAM-TSC)和结节病是三种罕见疾病。在这里,我们据我们所知,首次描述了一名同时患有这三种疾病的患者。
一名 47 岁女性,患有 LAM-TSC 和原发性胆汁性肝硬化/自身免疫性肝炎重叠综合征。在随访过程中,高分辨率胸部 CT 扫描(HRTC)证实存在多发性囊肿和微结节性混浊,符合多灶性微结节性肺泡细胞增生症(MMPH),并显示多个肺门-纵隔对称的淋巴结病,提示结节病。同时,双侧前臂出现皮下结节。皮肤活检显示肉芽肿性皮炎伴类肉瘤样肉芽肿。诊断为 I 期肺结节病。由于患者既没有全身受累,也没有呼吸功能损害,因此没有启动结节病的治疗。
存在一种以上的罕见疾病应该挑战潜在共同潜在机制的概念,因为同时存在不同发病机制的不同情况的先验概率很低,尤其是在罕见疾病的情况下。我们推测,涉及 mTOR 和 MAPK 的途径失调及其相互作用可能在其他疾病的发病机制中发挥作用,包括结节病。